Results 61 to 70 of about 9,616 (163)
Intrapleural Fibrinolytic Therapy in Pediatric Loculated Pleural Effusion: A Case Report [PDF]
Indian Journal of Respiratory CareIntroduction: Pleural effusion drainage in addition to antibiotics is used for the management of empyema and complex parapneumonic effusions (CPE). Fibrinolytics aid in drainage because fibrin adhesions create loculations in the pleural space.
Rhea P Gandhi +2 more
doaj +1 more source
The Journal of Association of Chest PhysiciansBackground: Pleural effusion involves the accumulation of fluid between the parietal and visceral pleura. When complicated by severe intrapleural inflammation, fibrous septations can form, leading to loculated effusions that are challenging to manage ...
Nandita Purohit +4 more
doaj +1 more source
Brazilian Journal of Cardiovascular Surgery, 1991 A utilização de agentes trombolíticos nas primeiras horas do infarto agudo do miocárdio tem sido aceita como um dos principais métodos de limitar-se a extensão do infarto.
Hermínio Vega +8 more
doaj
Fibrinolytic activity of Amirkabiria odoratissima Mozaffarian
Journal of Medicinal Plants, 2005 Background: fibrinolytic agents like streptokinase (SK) and urokinase (UK) are urgent treatment of thromboembolism. Besides thrombolysis, these medications have side effect like: generalized lytic state, serum fibrinogen decrease, effect on body ...
S Asgary +4 more
doaj
Bleeding, Thrombosis and Vascular BiologyIntroduction. Streptokinase (SK) is a widely used thrombolytic agent, but its clinical utility is limited due to its high immunogenicity, which results in rapid inactivation by antibodies. This study aimed to engineer a truncated variant of streptokinase
Mehwish Kanwal
doaj
Successful Use of Two Thrombolytic Drugs in Prosthetic Mitral and Aortic Valve Thrombosis
Pharmaceutical and Biomedical Research, 2019 Introduction: Prosthetic valve thrombosis is a rare and severe complication of valve replacement, most often encountered with a mechanical prosthesis.
Shayesteh Gheibi +3 more
doaj
In-Hospital Outcome of patients having Acute Myocardial Infarction with and without Streptokinase
Gomal Journal of Medical Sciences, 2009 Background: Acute myocardial infarction is the leading cause of death. Streptokinase is the most commonly used thrombolytic agent. This study was conducted to compare in-hospital outcome of patients with acute myocardial infarction receiving ...
Shimal Khan +4 more
doaj
Bolus streptokinase administration in acute myocardial infarction: features of hypotensive reaction
Российский кардиологический журнал, 2005 Hypotension prevalence and severity was investigated in two regimens of streptokinase (SK) administration in acute myocardial infarction (AMI). Group I (n = 17) received intravenous SK, 0.75 mln IE, in 10 minutes; Group II (n = 9) - 1.5 mln IE, in 45 ...
V. A. Stolyarov +2 more
doaj
Pilot experience with clopidogrel in the treatment of an .ST-elevation acute myocardial infarction
Терапевтический архив, 2004 Aim. To examine efficacy of clopidogrel before thrombolytic therapy (TLT) in patients with acute myocardial infarction (AMI). Material and methods. A total of 72 patients (48 males and 24 females) admitted to hospital within 6 hours since the onset of ...
S V Shalaev +4 more
doaj
A Non-randomized Clinical Trial on the Effectiveness and Complications of Two Different Streptokinase Dosages in Elderly Patients With ST-Elevation Myocardial Infarction (STEMI). [PDF]
CureusChandra S, Rai PJ, Singh N, Shivhare A.
europepmc +1 more source